Exercise Training in Childhood Cancer

NCT05289739 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 478

Last updated 2026-02-09

No results posted yet for this study

Summary

The purpose of this multicenter study is to evaluate a personalised and standardised exercise intervention for children and adolescents undergoing anti-cancer treatment.

Conditions

  • Pediatric Oncology

Interventions

BEHAVIORAL

Exercise training

Exercise training during intensive cancer treatment. Training mainly consists of age-appropriate and personalized endurance, strength, flexibility, balance/coordination and gait training. Three to five weekly training sessions lasting 30 to 60 minutes each for about eight to ten weeks (depending on the course of the cancer treatment).

Sponsors & Collaborators

  • University Hospital Heidelberg

    collaborator OTHER
  • Centre Leon Berard

    collaborator OTHER
  • Oxford Brookes University

    collaborator OTHER
  • Fondazione Monza e Brianza per il Bambino e la sua Mamma (MBBM)

    collaborator OTHER
  • European University of Madrid

    collaborator OTHER
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    collaborator OTHER
  • University Medical Centre Ljubljana

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • German Sport University, Cologne

    collaborator OTHER
  • University Hospital, Essen

    collaborator OTHER
  • Johannes Gutenberg University Mainz

    lead OTHER

Principal Investigators

  • Jörg Faber, Univ.-Prof. Dr. med. · Johannes Gutenberg University Mainz

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-25
Primary Completion
2026-01-26
Completion
2026-01-26

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05289739 on ClinicalTrials.gov